๐”– Bobbio Scriptorium
โœฆ   LIBER   โœฆ

Treatment of patients infected with chronic hepatitis C genotype 2 and 3: More data, more questions?

โœ Scribed by Ivo W. Graziadei; Wolfgang Vogel

Publisher
John Wiley and Sons
Year
2009
Tongue
English
Weight
255 KB
Volume
49
Category
Article
ISSN
0270-9139

No coin nor oath required. For personal study only.

๐Ÿ“œ SIMILAR VOLUMES

Genetic characterization of hypervariabl
Genetic characterization of hypervariable region 1 in patients chronically infected with hepatitis C virus genotype 2
โœ Xiaofeng Fan; Adrian M. Di Bisceglie ๐Ÿ“‚ Article ๐Ÿ“… 2001 ๐Ÿ› John Wiley and Sons ๐ŸŒ English โš– 164 KB ๐Ÿ‘ 2 views

## Abstract The hypervariable region 1 (HVR1) has been most reliably identified in the genome of HCV genotype 1 isolates and thought to possibly play a role in immune evasion and development of chronic infection. There are few studies, however, of other HCV genotypes to determine if they also have

IL28B genetic variation and treatment re
IL28B genetic variation and treatment response in patients with hepatitis C virus genotype 3 infection
โœ Amir Moghaddam; Espen Melum; Nils Reinton; Helmer Ring-Larsen; Hans Verbaan; Kri ๐Ÿ“‚ Article ๐Ÿ“… 2011 ๐Ÿ› John Wiley and Sons ๐ŸŒ English โš– 325 KB ๐Ÿ‘ 2 views

Polymorphisms near the IL28B gene, which code for interferon (IFN)-ฮป3, predict response to pegylated interferon-ฮฑ (PEG-IFN) and ribavirin treatment in hepatitis C virus (HCV) genotype 1 infected patients. Follow-up studies of the effect of IL28B gene in HCV non-genotype 1 infected patients have almo

Effects of interferon treatment on the a
Effects of interferon treatment on the antiviral T-cell response in hepatitis C virus genotype 1b- and genotype 2c-infected patients
โœ G Missale; E Cariani; V Lamonaca; A Ravaggi; A Rossini; R Bertoni; M Houghton; Y ๐Ÿ“‚ Article ๐Ÿ“… 1997 ๐Ÿ› John Wiley and Sons ๐ŸŒ English โš– 219 KB ๐Ÿ‘ 3 views

The viral genotype may influence the response to interferon sion and more efficient antiviral immune response, is still (IFN) treatment in chronic hepatitis C virus (HCV) infection. unclear. To characterize potential mechanisms responsible for this ef-Several factors including viral load, disease se